Mayo Clinic Comprehensive Cancer Center

Rochester, Minnesota 55905

3 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Or Metastatic Merkel Cell Carcinoma, Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer, Colorectal Cancer (CRC), Gynecologic Cancer, KRAS G12A, KRAS G12C, KRAS G12D, KRAS G12R, KRAS G12S, KRAS G12V

Studies at this site

• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors — Recruiting now
• Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma — Recruiting now
• A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes — Recruiting now
• A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors — Running, not enrolling
• Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer — Running, not enrolling
• A Study to Investigate LYL845 in Adults With Solid Tumors — Stopped early